FRANKFURT (Reuters) – German drugmaker Bayer said its drug Nexavar reached a goal of improving the survival of patients with a certain type of thyroid cancer in a late-stage trial.
It said on Thursday it plans to submit data from the trial as the basis for marketing approval of Nexavar to treat radioactive iodine refractory differentiated thyroid cancer.
(Reporting by Maria Sheahan)
Health News Headlines – Yahoo! News
Title Post: Bayer’s Nexavar meets goal in thyroid cancer trial
Url Post: http://www.news.fluser.com/bayers-nexavar-meets-goal-in-thyroid-cancer-trial/
Link To Post : Bayer’s Nexavar meets goal in thyroid cancer trial
Rating:
100%
based on 99998 ratings.
5 user reviews.
Author:
Thanks for visiting the blog, If any criticism and suggestions please leave a comment
Bayer’s Nexavar meets goal in thyroid cancer trial
This article
Bayer’s Nexavar meets goal in thyroid cancer trial
can be opened in url
http://whynewster.blogspot.com/2013/01/bayers-nexavar-meets-goal-in-thyroid.html
Bayer’s Nexavar meets goal in thyroid cancer trial
